TAIM
TAK icon

TD Ameritrade Investment Management’s Takeda Pharmaceutical TAK Stock Holding History

TD Ameritrade Investment Management’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-134
Closed -$2K – 434
2023
Q2 		$2K Hold
134
– – ﹤0.01% 477
2023
Q1 		$2K Sell
134
-283
-68% -$4.51K ﹤0.01% 508
2022
Q4 		$7K Sell
417
-373
-47% -$5.21K ﹤0.01% 419
2022
Q3 		$10K Sell
790
-190
-19% -$2.64K ﹤0.01% 389
2022
Q2 		$14K Sell
980
-626
-39% -$8.94K ﹤0.01% 404
2022
Q1 		$23K Sell
1,606
-429
-21% -$6.3K ﹤0.01% 408
2021
Q4 		$28K Sell
2,035
-694
-25% -$9.73K ﹤0.01% 389
2021
Q3 		$49K Buy
2,729
+302
+12% +$5.07K ﹤0.01% 330
2021
Q2 		$41K Sell
2,427
-788
-25% -$13.4K ﹤0.01% 361
2021
Q1 		$59K Hold
3,215
– – ﹤0.01% 318
2020
Q4 		$59K Buy
3,215
+486
+18% +$8.53K ﹤0.01% 318
2020
Q3 		$49K Sell
2,729
-117
-4% -$2.13K ﹤0.01% 330
2020
Q2 		$51K Sell
2,846
-784
-22% -$14.1K ﹤0.01% 308
2020
Q1 		$55K Sell
3,630
-514
-12% -$9.32K ﹤0.01% 285
2019
Q4 		$82K Buy
4,144
+279
+7% +$5.34K ﹤0.01% 262
2019
Q3 		$66K Buy
3,865
+145
+4% +$2.51K ﹤0.01% 253
2019
Q2 		$66K Buy
3,720
+983
+36% +$17.9K ﹤0.01% 231
2019
Q1 		$56K Buy
2,737
+43
+2% +$865 ﹤0.01% 237
2018
Q4 		$45K Buy
+2,694
New +$45.5K ﹤0.01% 235

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TD Ameritrade Investment Management's TAK Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Takeda Pharmaceutical (TAK) in Q3 2023, closing a stake of 134 shares — an estimated $2K sold.

TD Ameritrade Investment Management first reported a position in TAK in Q4 2018 and held it in 19 quarters. The position peaked at $82K in Q4 2019. 313 funds tracked by Wall St. Rank hold TAK as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Takeda Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 134 Takeda Pharmaceutical shares in Q3 2023, an estimated $2K.
  • TD Ameritrade Investment Management first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 19 quarters.
  • TD Ameritrade Investment Management's Takeda Pharmaceutical position peaked at $82K in Q4 2019.
  • 313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.